Similarly, PERK also contributes to ECM reorganization in breast cancer and overexpression of ATF4, which is a component of PERK pathway, induces cell invasion and metastasis, stimulating MMP2 and MMP7 expression in ESCC [13]. This evidence concerns the gene EIF2AK3 and esophageal squamous cell carcinoma.